Recurrent tonsillitis is commonly seen in children and this has many adverse effects on the normal growth and development of the child, missing of school days, economic burden of treatment etc. are few to name. About 30 million children develop tonsillitis with frequent exposure to bacterial and viral infections. The chronic tonsillitis wherein the tonsil gland gets inflamed and enlarged repeatedly, after treatment the size remains same though the inflammation subsides. This leads to obstruction in the throat both to airways as well as digestive tract. According to Ayurvedic classics, various internal medicines and procedures are advocated in the management of Mukharogas. In general, the drugs selected for treatment should have Lekhana, Shothahara, Pachana, Ropana, Rakthashambana and Vedanasthapana properties. One such polyherbal preparation is Dashamoolaharitaki Avaleha mentioned in Svayathu Chikitsa by Acharya Vagbhata, which is widely used in clinics for management of Tundikeri. In the present scenario scientific validation about the success of these treatments is required. Therefore an open label clinical study was designed to prove the effect of Dashamoolaharitaki Avaleha in Tundikeri. Materials and Methods: An open trial single group clinical study with minimum of 30 patients between the age group of 5 to 15 years with Tundikeri over a period of 30 days. Result: The clinical study showed highly significant results in relieving the clinical signs and symptoms of Tundikeri. Discussion: The Dashamoolaharitaki Avaleha was found therapeutically effective and safe to be administered in children and the mode of action was elaborated to substantiate the results.
Ayurvedic classics have described many diseases amongst which Jwara stands first because of its uniqueness to make everyone suffer, since birth to death. Jwara being one of the commonest symptoms which accompanies almost all constitutional diseases has been coined with the term Rogadhipathi. Fever is defined as temperature in rectum more than 100.4°F (38°C), in oral cavity above 99.5°F (37.5°C) or in axilla above 99°F (37. 2°C). If we don’t treat fever in its earlier stage, there will be more chances of hyperpyrexia which may cause febrile convulsions which leads to brain damage. Therefore, it is necessary to control fever at its earlier stage. One such Jwarahara formulation is Mukkaamukkatukaadi Gulika and Kiratatikta which is converted into syrup form to overcome the palatability issues. A sample size of 30 patients was selected by simple random sampling method and 15 patients were allotted in two groups. It was planned to compare the result between Mukkaamukkatukaadi syrup in Group A study group for STG and LTG and Kiratatikta syrup in Group B control group for STG and LTG. On STG comparison, the difference in mean in Group A and Group B were 0.49,0.44 before treatment changed to 0.96 and 0.98 after treatment respectively. On LTG comparison, the difference in mean in Group A and Group B were 0.49, 0.44 before treatment changed to 2.02 and 1.96 after follow up respectively. This depicts both the formulations effective when consumed for longer duration. From the results and observations it can be concluded that Group A and Group B are equally effective and equally significant on reducing the temperature in both STG and LTG. No adverse drug reaction was found during the study.
An open clinical trial was conducted to evaluate the efficacy of Hingwadichoorna on acute attack of Bronchial Asthma in children at SDM College of Ayurveda & Hospital, Kuthpady, Udupi. The trial was conducted on 34 patients, Hingwadichoorna was given in children of age group of 5years to 9yrs 11 months.The medicine was given 6 th hourly in a 4 divided dose per day for 7 days and with a follow up of 14 days. The response was assessed using various clinical, quantitative parameters and analyzed statistically using paired't' test and Wilcoxon Signed Rank Test. Statistically significant results obtained in subjective parameter and peak expiratory flow rate and hemoglobin, AEC. Study showed Hingwadichoorna is effective in combating the signs and symptoms of Tamakaswasa.
Alternate hemiplegia of childhood is a rare condition characterized by recurrent temporary episodes of hemiplegic attacks that affect one or the other side of the body. The clinical manifestations may begin at the neonatal period up to the age of 4 years. The reported prevalence is estimated at 1/100000 in children under 16 years old. There are, as of yet, no specific therapies that are uniformly effective in eliminating the episodes associated with AHC. AHC childhood can be correlated with Ayurvedic concept of Skandagraha. Here a case of 8 year old male child had come to our hospital with recurrent hemiplegic attacks having history of involuntary movements. At the end of 10days of IP treatment which included Panchakarma procedures along with internal medication resulted in 5-10% improvement in the overall effect of therapy. Followed by Shamanachikitsa 30-40% improvement was observed. Hence a humble attempt has been made to explore the case.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.